Skip to main content
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
nevena.skroza@uniroma1.it
Nevena Skroza
Ricercatore
Struttura:
DIPARTIMENTO DI SCIENZE E BIOTECNOLOGIE MEDICO-CHIRURGICHE
E-mail:
nevena.skroza@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Publications
Title
Published on
Year
Effectiveness of tralokinumab in different phenotypes of atopic dermatitis. A real-world study
DERMATOLOGY AND THERAPY
2025
A real-world approach to Trifarotene treatment in patients with acne and acne sequelae based on the experience of the Italian Acne Board
DERMATOLOGY AND THERAPY
2025
Risankizumab versus Secukinumab: a real-world efficacy and cost per responder comparison in patients with psoriasis in Italy
DERMATOLOGY PRACTICAL & CONCEPTUAL
2025
Gender differences in adult atopic dermatitis and clinical implication: results from a nationwide multicentre study
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
2024
On the potential role of naturally occurring carboxylic organic acids as anti-infective agents: opportunities and challenges
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
2024
Efficacy and safety of tildrakizumab in elderly patients. Real-world multicenter study (ESTER - study)
JOURNAL OF DERMATOLOGICAL TREATMENT
2024
Extracellular vescicles in psoriasis. From pathogenesis to possible roles in therapy
FRONTIERS IN IMMUNOLOGY
2024
Interleukin-13 inhibitors in the treatment of atopic dermatitis. the role of tralokinumab
DERMATOLOGY PRACTICAL & CONCEPTUAL
2024
Efficacy and safety of intra-class switching from Ixekizumab to Secukinumab in patients with plaque psoriasis. A multicenter retrospective study
JOURNAL OF PERSONALIZED MEDICINE
2024
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study. IL PSO (Italian Landscape Psoriasis)
JOURNAL OF DERMATOLOGICAL TREATMENT
2024
Safe Integration of Encorafenib plus Binimetinib with Stereotactic Radiosurgery for Melanoma Brain Metastases: a Case Report
LA CLINICA TERAPEUTICA
2024
Rapid efficacy of riSankizumab in pretibial psoriasis invOLVEment. RESOLVE
DRUGS IN CONTEXT
2024
Hyaluronic acid fillers for cosmetic and functional correction in thyroid eye disease
JOURNAL OF COSMETIC DERMATOLOGY
2024
Atopic Dermatitis Onset in a Melanoma Patient Under Pembrolizumab Therapy: A Case of Successful Treatment with Dupilumab
INDIAN JOURNAL OF DERMATOLOGY
2024
Rapid response on facial psoriasis to bimekizumab: case series
DRUGS IN CONTEXT
2024
OPT-In; Optimized patient treatment outcomes in plaque psoriasis. A 3-year state-transition treatment-sequencing model in the italian setting
DERMATOLOGY AND THERAPY
2024
Successful treatment with Bimekizumab of a psoriatic patient undergoing hemodialysis. A case report and review of the literature
JOURNAL OF CLINICAL MEDICINE
2024
18F-FDG PET-CT scans in oncology patients treated with hyaluronic acid filler: not always a pitfall
CASE REPORTS IN ONCOLOGICAL MEDICINE
2024
Extreme makeover filler edition. Non-surgical correction for facial deformities post-trauma
JOURNAL OF COSMETIC DERMATOLOGY
2024
Generalized eruptive keratoacanthoma (GEKA) after Pfizer mRNABNT162b2 (Comirnaty®) COVID-19 vaccination successfully treated with Cemiplimab
VIRUSES
2024
1
2
3
4
5
6
next >
last »
ERC
LS7
LS7_4
LS7_9
KET
Life-science technologies & biotechnologies
Interessi di ricerca
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma